NCT00880334 Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC Status COMPLETED Phase PHASE2
NCT00879034 A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria Status COMPLETED Phase PHASE2
NCT00869999 Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00866723 Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer Status TERMINATED Phase PHASE2
NCT00864864 Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma Status COMPLETED Phase EARLY_PHASE1
NCT00856180 Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies Status COMPLETED Phase PHASE2
NCT00856050 Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma Status COMPLETED Phase PHASE2
NCT00844077 Preliminary Longitudinal Validation of Biomarkers Predictive of Barrett's Esophagus Status COMPLETED Phase N/A
NCT00842257 Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00834093 A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma Status COMPLETED Phase PHASE2
NCT00831571 Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin Status COMPLETED Phase N/A
NCT00827359 Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT00821080 Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma Status COMPLETED Phase PHASE1
NCT00815919 Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft Versus Host Disease Status COMPLETED Phase PHASE2
NCT00813293 Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer Status COMPLETED Phase PHASE2
NCT00809588 Vaccination With Autologous, Lethally Irradiated Melanoma Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Stimulating Factor (GMSF) Status COMPLETED Phase PHASE1